Charles Schwab’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.39M Buy
1,232,535
+76,691
+7% +$86.7K ﹤0.01% 2787
2025
Q1
$1.69M Sell
1,155,844
-32,994
-3% -$48.2K ﹤0.01% 2665
2024
Q4
$2.53M Buy
1,188,838
+9,990
+0.8% +$21.3K ﹤0.01% 2606
2024
Q3
$3.3M Buy
1,178,848
+447
+0% +$1.25K ﹤0.01% 2555
2024
Q2
$2.75M Buy
1,178,401
+319,925
+37% +$745K ﹤0.01% 2591
2024
Q1
$3.84M Buy
858,476
+125,641
+17% +$562K ﹤0.01% 2384
2023
Q4
$2.35M Sell
732,835
-48,493
-6% -$156K ﹤0.01% 2564
2023
Q3
$2.48M Buy
781,328
+115,997
+17% +$368K ﹤0.01% 2537
2023
Q2
$3.31M Buy
665,331
+15,046
+2% +$74.8K ﹤0.01% 2390
2023
Q1
$3.21M Buy
650,285
+1,490
+0.2% +$7.36K ﹤0.01% 2385
2022
Q4
$4.08M Buy
648,795
+13,340
+2% +$83.9K ﹤0.01% 2315
2022
Q3
$6.86M Buy
635,455
+91,346
+17% +$987K ﹤0.01% 2047
2022
Q2
$6.2M Buy
544,109
+13,450
+3% +$153K ﹤0.01% 2096
2022
Q1
$4.84M Sell
530,659
-6,386
-1% -$58.2K ﹤0.01% 2297
2021
Q4
$8.01M Buy
537,045
+6,049
+1% +$90.3K ﹤0.01% 2116
2021
Q3
$13.6M Sell
530,996
-103,373
-16% -$2.66M ﹤0.01% 1831
2021
Q2
$16.5M Buy
634,369
+71,315
+13% +$1.86M 0.01% 1719
2021
Q1
$19.9M Buy
563,054
+13,047
+2% +$461K 0.01% 1538
2020
Q4
$13.9M Buy
550,007
+10,124
+2% +$256K 0.01% 1658
2020
Q3
$20.4M Buy
539,883
+9,017
+2% +$340K 0.01% 1191
2020
Q2
$22.7M Buy
530,866
+128,713
+32% +$5.51M 0.01% 1081
2020
Q1
$7.82M Buy
402,153
+6,706
+2% +$130K ﹤0.01% 1601
2019
Q4
$10.3M Buy
395,447
+8,627
+2% +$224K 0.01% 1655
2019
Q3
$10.5M Buy
386,820
+195,477
+102% +$5.33M 0.01% 1578
2019
Q2
$5.14M Buy
191,343
+38,579
+25% +$1.04M ﹤0.01% 1959
2019
Q1
$4.42M Buy
152,764
+8,637
+6% +$250K ﹤0.01% 2027
2018
Q4
$3.88M Buy
+144,127
New +$3.88M ﹤0.01% 2030